Explore Ventas
Core profile pages, annual revenue records, and related research hubs for this company.
Leadership History
1 leader · Full leadership timeline
Ventas operates with 400 employees and generates $4.53 billion in annual revenue — roughly $11.3 million in revenue per employee, a ratio that reflects the REIT structure's fundamental leverage: the company owns assets worth many times its own headcount cost, and those assets generate income through lease agreements and operator management contracts rather than requiring large internal operating teams. The $23.5 billion market capitalization and the 400-person organization sit on top of a portfolio spanning senior housing communities, outpatient medical facilities, and life science infrastructure that took decades to assemble. Debra A. Cafaro has led the company since 2003 — an unusual leadership tenure in a sector where CEOs change frequently. Cafaro joined when the company was emerging from a predecessor entity's financial difficulties and has since presided over a portfolio transformation that included the 2021 merger with HCP and multiple portfolio recycling cycles that moved capital from declining asset types toward higher-growth opportunities. The SHOP (Senior Housing Operating Properties) segment, where Ventas participates directly in operating income rather than collecting a fixed lease payment, allows daily room rate adjustments that capture inflation and local demand fluctuations faster than any conventional lease structure permits. The demographic tailwind behind the senior housing business is among the most reliable in real estate: the US population aged 75 and older will roughly double over the 2020-2040 period, creating sustained demand for both assisted living and independent senior housing. Medical tenants in Ventas's outpatient facilities cost more than $100,000 per physician to relocate, creating switching costs that anchor long-term occupancy regardless of broader commercial real estate market conditions. The life science infrastructure segment — laboratory and research buildings housing biotech and pharmaceutical research operations — serves a different demand driver than senior housing but benefits from similar tenant stickiness. Research operations involving specialized laboratory equipment, biosafety requirements, and proprietary experiments simply cannot be moved without significant cost and disruption to ongoing work.
Chairman and Chief Executive Officer
Cafaro has been instrumental in the company's strategic evolution, spearheading the ruthless pivot away from skilled nursing toward senior housing and medical office buildings, and orchestrating transformative acquisitions like the 2010 Vencor merger and the 2021 HCP merger, fundamentally changing the company's business model and unlocking massive shareholder value.
Ventas faces risks from senior-housing occupancy, labor costs, operator performance, interest rates, refinancing costs, property values, healthcare regulation, reimbursement pressure, and capital-market access.
Debra A. Cafaro is Chairman and Chief Executive Officer of Ventas.
Ventas leadership focuses on senior housing, healthcare real estate allocation, capital access, operator relationships, and portfolio growth.
Yes. Ventas, Inc. trades on the New York Stock Exchange under ticker symbol VTR.
This profile uses about 400 corporate employees for Ventas; portfolio operations also involve operators and partners.